CINECA IRIS Institutional Research Information System

BASILE, Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.021
EU - Europa 1.583
AS - Asia 802
SA - Sud America 172
OC - Oceania 41
AF - Africa 36
Totale 4.655
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.944
IT - Italia 499
CN - Cina 280
DE - Germania 180
JP - Giappone 135
IE - Irlanda 129
FR - Francia 107
SG - Singapore 92
SE - Svezia 89
BR - Brasile 73
ES - Italia 72
TR - Turchia 62
DK - Danimarca 57
GB - Regno Unito 55
PL - Polonia 55
CA - Canada 46
UA - Ucraina 44
FI - Finlandia 43
VN - Vietnam 43
AR - Argentina 42
AT - Austria 40
IN - India 40
RU - Federazione Russa 38
AU - Australia 36
HU - Ungheria 35
CO - Colombia 30
HK - Hong Kong 30
BE - Belgio 28
ID - Indonesia 27
KR - Corea 25
MX - Messico 23
CH - Svizzera 20
GR - Grecia 19
NL - Olanda 16
TW - Taiwan 16
DZ - Algeria 15
PT - Portogallo 15
IL - Israele 12
CL - Cile 10
BA - Bosnia-Erzegovina 7
EC - Ecuador 7
TH - Thailandia 7
MY - Malesia 6
PE - Perù 6
RS - Serbia 6
TN - Tunisia 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
HR - Croazia 5
PH - Filippine 5
SI - Slovenia 5
DO - Repubblica Dominicana 4
JO - Giordania 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
VE - Venezuela 4
OM - Oman 3
PK - Pakistan 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
CU - Cuba 2
IR - Iran 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
BY - Bielorussia 1
EG - Egitto 1
FJ - Figi 1
LT - Lituania 1
LU - Lussemburgo 1
ME - Montenegro 1
MU - Mauritius 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 4.655
Salva come PNG Salva come JPEG
Città #
Chandler 242
Ann Arbor 139
Fairfield 137
Dublin 123
Beijing 97
Torino 91
Ashburn 90
Woodbridge 79
Singapore 78
Seattle 68
Cambridge 67
Redwood City 67
Wilmington 61
Houston 59
Turin 50
Nyköping 49
Jacksonville 42
Munich 36
Vienna 33
Guangzhou 29
Medford 29
Jakarta 27
Princeton 27
Dong Ket 26
Würzburg 26
Shanghai 24
Villeurbanne 22
Milan 21
Okazaki 21
Rochester 21
Pisa 20
Budapest 19
Fremont 19
Buenos Aires 18
Los Angeles 18
New York 18
Paris 18
Bogotá 17
Dearborn 16
Ankara 15
Florence 15
Tokyo 15
Istanbul 14
Taipei 13
Lappeenranta 12
Moscow 12
Rio de Janeiro 12
Boston 11
Brisbane 11
Fukuoka 11
Seoul 11
Uberlândia 11
Warsaw 11
Chengdu 10
Hangzhou 10
Hong Kong 10
Rome 10
San Diego 10
Szekszárd 10
Zurich 10
Athens 9
Delhi 9
Helsinki 9
Madrid 9
Amsterdam 8
Berlin 8
Curitiba 8
London 8
Portland 8
Brescia 7
Brussels 7
Girona 7
Norwalk 7
Polska 7
Soliera 7
Bad Zwischenahn 6
Barcelona 6
Bethesda 6
Bozeman 6
Catania 6
Gumyojicho 6
Lima 6
Logroño 6
Lublin 6
Matawan 6
Naples 6
Norfolk 6
Osaka 6
Pasto 6
Alaşehir 5
Belgrade 5
Canberra 5
Chicago 5
Cleveland 5
Durham 5
Florianópolis 5
Fürstenzell 5
General Rodriguez 5
Hamamatsu 5
Hefei 5
Totale 2.545
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.124
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 410
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 304
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 276
Aspetti medico legali e concetto di responsabilità in medicina d'emergenza - urgenza 256
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 250
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 204
Diagnosi e terapia del carcinoma corticosurrenalico 174
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 170
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 154
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 116
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 111
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 107
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 105
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 100
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma 96
Mitotane: new facts for an old drug 93
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 77
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 76
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 74
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 65
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 55
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 54
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 46
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 42
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 36
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 33
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 31
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 26
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion 25
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 21
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 21
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. 17
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 17
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 17
Adrenal cortical carcinoma: mitotane and beyond 16
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 9
Totale 4.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.774
article - articoli 0
book - libri 0
conference - conferenze 1.834
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.608
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020391 0 0 0 39 25 54 28 47 66 48 37 47
2020/2021699 59 35 63 37 43 43 47 54 39 70 101 108
2021/2022914 74 50 58 76 82 65 67 68 62 88 130 94
2022/20231.083 92 107 50 86 80 176 66 82 125 47 85 87
2023/2024904 86 125 62 85 83 76 47 76 28 74 86 76
2024/2025276 61 88 105 22 0 0 0 0 0 0 0 0
Totale 4.808